We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

128 hedge funds and large institutions have $904M invested in Sarepta Therapeutics in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

39% less call options, than puts

Call options by funds: $120M | Put options by funds: $196M

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$120M
Puts
$196M
Net Calls
-$75.6M
Net Calls Change
-$75.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TAM
76
Tocqueville Asset Management
New York
$721K +$678K +18,950 New
BA
77
BlackRock Advisors
Delaware
$720K +$677K +18,934 New
TD Asset Management
78
TD Asset Management
Ontario, Canada
$670K +$629K +17,600 New
DekaBank Deutsche Girozentrale
79
DekaBank Deutsche Girozentrale
Germany
$659K +$618K +17,283 New
SIM
80
SSI Investment Management
California
$598K +$563K +15,747 New
BLM
81
Bennett Lawrence Management
New York
$592K +$556K +15,550 New
NTCOC
82
Northern Trust Company of Connecticut
Connecticut
$540K +$507K +14,190 New
FAAS
83
First Allied Advisory Services
California
$497K +$467K +13,054 New
PCM
84
Prelude Capital Management
New York
$495K +$465K +13,000 New
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
$485K +$456K +12,762 New
BG
86
BlackRock Group
United Kingdom
$484K +$455K +12,712 New
PNC Financial Services Group
87
PNC Financial Services Group
Pennsylvania
$426K +$401K +11,200 New
Millennium Management
88
Millennium Management
New York
$418K +$393K +11,000 New
HI
89
HBK Investments
Texas
$415K +$390K +10,900 New
Citigroup
90
Citigroup
New York
$412K +$387K +10,831 New
Principal Financial Group
91
Principal Financial Group
Iowa
$403K +$379K +10,601 New
NFA
92
Nationwide Fund Advisors
Ohio
$390K +$367K +10,260 New
OC
93
Oppenheimer & Co
New York
$381K +$358K +10,019 New
B
94
Baird
Wisconsin
$307K +$289K +8,070 New
BFM
95
Boston Financial Management
Massachusetts
$307K +$289K +8,078 New
AL
96
Airain Ltd
Guernsey
$294K +$276K +7,717 New
GLRA
97
Gerald L. Ray & Associates
Texas
$272K +$256K +7,150 New
Mitsubishi UFJ Asset Management
98
Mitsubishi UFJ Asset Management
Japan
$259K +$243K +6,800 New
CA
99
Commerzbank Aktiengesellschaft
Germany
$257K +$242K +6,764 New
Jane Street
100
Jane Street
New York
$248K +$233K +6,515 New
2 3
4
5 6

SRPT Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q2 2013, worth a combined $904M.

Buyers outnumbered sellers: 128 funds opened new SRPT positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Sarepta Therapeutics (SRPT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $904M of Sarepta Therapeutics stock for Q2 2013.
  • 128 funds opened new Sarepta Therapeutics positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.